CAD Pharma

What CAD Pharma does

CAD Pharma is a Bangalore-headquartered pharmaceutical sourcing and trading intermediary incorporated in February 2003 under the legal name CAD Pharma Inc. The firm operates as a B2B bridge between Indian drug manufacturers and buyers in regulated markets (United States and Europe), and concurrently imports Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, fine and specialty chemicals, and excipients from China and Europe for redistribution in India. It markets products on both exclusive and non-exclusive representation agreements with multiple principals and offers regulatory affairs and documentation support as a value-add beyond pure logistics.

The company's portfolio spans six product categories: APIs (including regulatory and non-regulatory grades for molecules such as Alendronate Sodium, Amlodipine Besylate, Clindamycin, and Metformin HCl), pharmaceutical intermediates (cardiovascular, anti-diabetic, anti-cancer, and antibiotic categories with CAS-numbered offerings), excipients (Hypromellose, Microcrystalline Cellulose, Povidone, and other formulation aids), herbal extracts (Ashwagandha, Bacopa, Boswellia, Green Tea, Guggul, and Gymnema Sylvestre), fine chemicals (pyridine, pyrimidine, and xylene derivatives and specialty synthesis starting materials), and hormones and steroids (testosterone, nandrolone, DHEA, progesterone, estradiol, and boldenone series). CAD Pharma's "technology" stack is minimal: a static informational website with downloadable PDF product catalogs, no public API or SDK, and no proprietary software platform. Operational differentiation rests on regulatory documentation expertise and access to GMP- and USFDA-inspected manufacturing partners (e.g., Zoledronic Acid monohydrate US FDA approval 2014, Tamsulosin Hydrochloride US FDA inspection 2015).

The business model is a transaction-fee sourcing and representation model across all six product categories. Revenue mechanics are quote-based B2B distribution with no publicly disclosed pricing. The go-to-market is direct enterprise sales from Bangalore supported by CPHI trade show participation (Mumbai 2016, Barcelona 2016, Shanghai 2013, and API China 2015) and a network of nine disclosed associate manufacturers, of which Duke Chem (EDMF/Brinzolamide) and ALP (Brinzolamide and Febuxostat intermediates, US FDA inspection in progress) are flagged as core partners. Customer segments include pharmaceutical manufacturers in Europe and the United States (regulated, anchored on exclusive representation), and Indian customers split between regulatory and non-regulatory markets. The company is privately held and founder-owned with no disclosed institutional capital, no subsidiaries, and no headcount expansion signals; financial details are not publicly disclosed.

Name

CAD Pharma

Legal name

CAD Pharma Inc.

Website

https://cadpharma.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

CAD Pharma is a Bangalore-based pharmaceutical sourcing intermediary, founded 2003, connecting Indian manufacturers with enterprise buyers in Europe and the US while importing APIs, intermediates, excipients, fine chemicals, herbal extracts, and hormones into the Indian market.

Ownership category

akta.pro rank

Product category

Pharmaceutical Sourcing & Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Chemical and Allied Products Merchant Wholesalers (4246)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

akta.pro secondary industries

Full-Line Pharmaceutical Wholesalers (HLAIAJAA), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical sourcing
• API distribution
• Pharmaceutical intermediates
• Regulatory affairs services
• Excipient supply

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. API Exports: Exclusively represents manufacturers in Europe and USA as their Indian counterpart, assisting those sourcing APIs, intermediates, Excipients and Finished dosages from reliable Indian manufacturers. Exports of APIs, Pharmaceutical Intermediates, Fine Chemicals & Excipients from India.
2. Import and Distribution: Represents companies across the globe on an exclusive and non-exclusive basis, marketing their products in India. Indenting & Imports of APIs, Pharmaceutical Intermediates, Fine & Speciality Chemicals mainly from China and Europe. Developed good customer base in India for regulatory and non-regulatory markets.
3. Sourcing Intermediates from China: Sourcing intermediates from China through associates at competitive prices. Provides finished dosage forms sourced from GMP Approved Facilities as per customer requirements.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

Core offering

CAD Pharma is a B2B pharmaceutical sourcing, importing, and exporting company that supplies Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, excipients, fine chemicals, herbal extracts, and hormones & steroids. The company acts as the exclusive or non-exclusive Indian representative for manufacturers in Europe, the USA, and China, while also marketing global manufacturers' products within India. In addition to product trade, the company provides regulatory affairs support, documentation assistance, and business development services including DCGI product registrations.

Product overview

CAD Pharma is a pharmaceutical sourcing and trading company established in 2003, operating as a young pharmaceutical company incorporated in February 2003 with a professional set-up in Bangalore, India. The company offers a diverse portfolio of pharmaceutical products including Active Pharmaceutical Ingredients (APIs), Pharmaceutical Intermediates, Excipients, Herbal Products/Extracts, Fine Chemicals, and Hormones & Steroids. The core offering is pharmaceutical sourcing services where CAD Pharma acts as a sourcing partner and marketing representative for manufacturers, assisting customers in sourcing APIs, Finished Formulations, Excipients, and Intermediates primarily from India for regulated and non-regulated markets. Additionally, the company provides regulatory affairs support, documentation assistance, and business development services.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Pharmaceutical Ingredients (APIs) Supply of Active Pharmaceutical Ingredients for regulated and non-regulated markets, covering cardiovascular, anti-diabetic, antibiotic, and other therapeutic categories. Targeted at pharmaceutical manufacturers in Europe, USA, and India.
• Pharmaceutical Intermediates Pharmaceutical intermediates supplied across cardiovascular, anti-diabetic, anti-cancer, and antibiotic drug categories with detailed CAS numbers. Sourced from Indian and Chinese manufacturers for pharmaceutical manufacturing clients.
• Excipients Pharmaceutical excipients including Hypromellose, Microcrystalline Cellulose, Povidone, Sodium Starch Glycolate, various gluconates, Cross Carmellose Sodium, and Dextrose Anhydrous, used as inactive ingredients in drug formulations.
• Herbal Products and Extracts Herbal extracts marketed under CAD Pharma's product line, including Ashwagandha Extract, Bacopa Monnieri Extract, Boswellia Extract, Green Tea Extract, Guggul Extract, and Gymnema Sylvestre Extract. Targeted at pharmaceutical and nutraceutical manufacturers.
• Fine Chemicals Fine chemicals including pyridine derivatives, pyrimidine derivatives, xylene derivatives, and various specialty chemicals used as starting materials in pharmaceutical synthesis.
• Hormones and Steroids Hormonal and steroid products including testosterone series, nandrolone series, DHEA derivatives, progesterone, estradiol, boldenone series, and other steroid intermediates. Targeted at pharmaceutical manufacturers.
• Sourcing and Regulatory Services Business development, sourcing partner, regulatory assistance, product registrations with DCGI, market surveys, and marketing assistance services for pharmaceutical products. Targeted at pharmaceutical manufacturers seeking Indian market entry and regulatory support.

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered minor and core.

• PolyPharmaminorStrategic or Co-development PartnerListed as associate partner in pharmaceutical sourcing network. Products sourced through this partner.
• GentecminorStrategic or Co-development PartnerAssociate partner for pharmaceutical sourcing operations.
• CPRIminorStrategic or Co-development PartnerAssociate partner for pharmaceutical sourcing operations.
• GotopharmminorStrategic or Co-development PartnerAssociate partner for pharmaceutical sourcing operations.
• Duke ChemcoreStrategic or Co-development PartnerKey manufacturing partner supplying intermediates. Duke Chem provides EDMF for Brinzolamide and other products. Long-standing working relationship.
• PharmanoidminorStrategic or Co-development PartnerAssociate partner for pharmaceutical sourcing operations.
• PackminorStrategic or Co-development PartnerAssociate partner for pharmaceutical sourcing operations.
• HunanminorStrategic or Co-development PartnerChinese manufacturer partner for sourcing intermediates.
• ALPcoreStrategic or Co-development PartnerKey manufacturing partner for Brinzolamide and Febuxostat intermediates. US FDA inspection scheduled from ALP facility. Leading supplier of Dorzolamide & Brinzolamide intermediates.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Jubilant Ingrevia: Indian specialty chemicals and API/CDMO player with DMF filings and USFDA-approved facilities, distributing APIs and intermediates globally — directly comparable business model to CAD Pharma but at much larger scale, targeting the same regulated and non-regulated buyer base.
• Divis Laboratories: Pure-play Indian API and intermediates manufacturer/exporter serving global generic and innovator pharma. Directly comparable in product mix and India-to-US/EU API distribution, with extensive USDMF portfolio.
• Sequent Scientific: India-based API and animal-health manufacturer/distributor; comparable in targeting specialty API niches and serving global regulated markets via a mix of manufacturing and trading partnerships.
• Centrient Pharmaceuticals: Amsterdam-headquartered, India-manufactured sustainable API producer serving global pharma; direct peer in India-to-world regulated API supply and EU/US regulatory affairs support.
• Vivimed Labs: Indian specialty chemicals and pharmaceutical intermediates company with global distribution; comparable in API intermediate sourcing, fine chemicals, and export-led business model.
• Hikal Ltd: Indian manufacturer of APIs, intermediates, and fine chemicals serving global pharma and agro customers; directly comparable in pharmaceutical intermediate sourcing and regulatory-grade supply.

Emerging players

• PharmaCompass: Global B2B platform connecting API buyers and suppliers from India; an emerging marketplace that overlaps with CAD Pharma's matchmaking/sourcing intermediary role and competes for the same supplier discovery workflow.

Broad incumbents

• Aurobindo Pharma: Large Indian vertically integrated generics and API manufacturer with global distribution; broader incumbent that competes at scale for the same regulated-market API and finished dosage RFPs that CAD Pharma's partners serve.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/cad-pharma-inc---india

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAD Pharma